Older adults represent the fastest-growing demographic of cannabis users, yet clinical data on safety, efficacy, and drug interactions in this population remains critically limited. Age-related changes in metabolism, polypharmacy concerns, and altered pharmacokinetics make evidence-based prescribing particularly challenging for clinicians treating patients over 60.
The University of Illinois Chicago is recruiting adults age 60 and older for cannabis research, addressing a significant gap in clinical evidence for geriatric cannabis use. This demographic faces unique considerations including altered drug metabolism, increased medication interactions, and age-related physiological changes that may affect cannabis pharmacokinetics and pharmacodynamics. Current prescribing guidelines for older adults are largely extrapolated from younger populations, creating uncertainty in clinical practice.
“This research is overdue — I regularly see patients over 60 seeking cannabis for pain, sleep, and other conditions, but I’m essentially flying blind on dosing and safety profiles specific to their age group. We desperately need age-stratified data to move beyond educated guesswork.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What is the clinical relevance of this cannabis research?
This research has been rated as having high clinical relevance (#80) with strong evidence that has direct clinical implications. The findings provide actionable information that can be applied in clinical practice.
Why is this research particularly important for geriatric medicine?
Older adults often take multiple medications and may be more sensitive to drug interactions and dosing considerations. Cannabis use in this population requires careful consideration of these factors to ensure safe and effective treatment.
What drug interaction concerns should clinicians be aware of?
Cannabis can interact with various medications commonly used in geriatric patients. Clinicians should review all medications and monitor for potential interactions when considering cannabis therapy in older adults.
How does dosing differ for geriatric patients using cannabis?
Geriatric patients typically require lower starting doses and slower titration schedules compared to younger adults. Age-related changes in metabolism and increased sensitivity necessitate a “start low, go slow” approach.
What should healthcare providers consider before recommending cannabis to older patients?
Providers should conduct a comprehensive medication review, assess for contraindications, and consider the patient’s overall health status. Close monitoring and gradual dose adjustments are essential for safe implementation in geriatric populations.
